#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA940322	B	Inhibition of CRM1-mediated nucleocytoplasmic transport of RevM5 mutant in HEK293 cells assessed as RevM5-GFP nuclear localization at 2 ug/ml after 2 hrs by fluorescence microscopy		39		cell-based format	Scientific Literature
2.	ALA940323	B	Inhibition of CRM1-mediated nucleocytoplasmic transport of HIV1 RevM5 mutant in human HeLa cells assessed as HIV1 RevM5-GFP nuclear localization at 25 nM after 2 hrs by fluorescence microscopy		1		cell-based format	Scientific Literature
3.	ALA940324	B	Inhibition of CRM1-mediated nucleocytoplasmic transport of HIV1 RevM5 mutant in human HeLa cells assessed as HIV1 RevM5-GFP nuclear localization at 10 ug/ml after 2 hrs by fluorescence microscopy		2		cell-based format	Scientific Literature
4.	ALA940330	B	Inhibition of CRM1-mediated nucleocytoplasmic transport of RevM5 mutant in HEK293 cells assessed as RevM5-GFP nuclear localization at 10 ug/ml after 2 hrs by fluorescence microscopy		39		cell-based format	Scientific Literature
5.	ALA941189	B	Inhibition of CRM1-mediated nucleocytoplasmic transport of RevM5 mutant in HEK293 cells assessed as RevM5-GFP nuclear localization at 0.4 ug/ml after 2 hrs by fluorescence microscopy		41		cell-based format	Scientific Literature
6.	ALA941190	B	Inhibition of CRM1-mediated nucleocytoplasmic transport of RevM5 mutant in HEK293 cells assessed as RevM5-GFP nuclear localization at 0.08 ug/ml after 2 hrs by fluorescence microscopy		46		cell-based format	Scientific Literature
7.	ALA1121233	B	Inhibition of CRM1-mediated nuclear export of Rio2 in human HeLa cells at 2 uM	Homo sapiens	4		cell-based format	Scientific Literature
8.	ALA1110148	B	Inhibition of CRM1-mediated nuclear export of Rio2 in human HeLa cells at 1 uM	Homo sapiens	1		cell-based format	Scientific Literature
9.	ALA1120676	B	Inhibition of CRM1-mediated hemagglutininin-tagged HIV1 Rev protein nuclear export in human HeLa cells assessed as nuclear localization at 5 uM after 12 hrs by indirect fluorescent antibody technique	Homo sapiens	1		cell-based format	Scientific Literature
10.	ALA1120677	B	Inhibition of CRM1-mediated hemagglutininin-tagged HIV1 Rev protein nuclear export in human HeLa cells assessed as nucleus localization after 12 hrs by indirect fluorescent antibody technique	Homo sapiens	5		cell-based format	Scientific Literature
11.	ALA1120678	B	Inhibition of CRM1-mediated hemagglutininin-tagged HIV1 Rev protein nuclear export in human HeLa cells assessed as nucleus localization at 25 uM after 12 hrs by indirect fluorescent antibody technique	Homo sapiens	1		cell-based format	Scientific Literature
12.	ALA3880038	B	Inhibition of Crm1 in human U2OS cells expressing GFP-fused HIV1 Rev assessed as decrease in nuclear export of GFP-fused HIV1 Rev after 1 hr by Hoechst 33258 staining-based assay	Homo sapiens	84		cell-based format	Patent Bioactivity Data
13.	ALA3880074	B	Inhibition of Crm1 in human H929 cells assessed as decrease in nuclear export of topoisomerase-2 by measuring caspase-3 levels at 0.1 to 10 uM preincubated for 16 hrs followed by addition of topoisomerase-2 inhibitor doxorubicin measured after 4 hrs by anti-caspase-3 assay	Homo sapiens	1		cell-based format	Patent Bioactivity Data
14.	ALA3880075	B	Inhibition of Crm1 in human MM1S cells assessed as potentiation of bortezomib-induced antiproliferative activity by measuring cell survival at 30 to 300 nM after 72 hrs by MTT assay	Homo sapiens	1		cell-based format	Patent Bioactivity Data
15.	ALA3880076	B	Inhibition of Crm1 in human MM1R cells assessed as potentiation of bortezomib-induced antiproliferative activity by measuring cell survival at 30 to 300 nM after 72 hrs by MTT assay	Homo sapiens	1		cell-based format	Patent Bioactivity Data
16.	ALA3880077	B	Inhibition of Crm1 in human HS-Sultan cells assessed as potentiation of bortezomib-induced antiproliferative activity by measuring cell survival at 30 to 300 nM after 72 hrs by MTT assay	Homo sapiens	1		cell-based format	Patent Bioactivity Data
17.	ALA3880078	B	Inhibition of Crm1 in human Jurkat cells assessed as potentiation of bortezomib-induced antiproliferative activity by measuring cell survival at 30 to 300 nM after 72 hrs by MTT assay	Homo sapiens	1		cell-based format	Patent Bioactivity Data
18.	ALA4024845	B	Inhibition of CRM1-mediated nucleocytoplasmic transport in human HeLa cells after 90 mins by immunofluorescence assay	Homo sapiens	3		cell-based format	Scientific Literature
19.	ALA4057069	B	Inhibition of CRM1-mediated nucleocytoplasmic transport of Riok2 in human HeLa cells at 1 uM after 90 mins by DAPI staining based microscopy relative to control	Homo sapiens	2		cell-based format	Scientific Literature
20.	ALA4057070	B	Inhibition of CRM1-mediated nucleocytoplasmic transport of Riok2 in human HeLa cells at 5 uM after 90 mins by DAPI staining based microscopy relative to control	Homo sapiens	1		cell-based format	Scientific Literature